NASDAQ

NASDAQ US (NASDAQ) Stocks

Filtering by confidence, sector, archetype, solvency, and lenses-in-buy is a subscriber feature. Subscribe to unlock every filter.
Showing 1501–1550 of 2815
Symbol Name Sector Verdict Confidence Archetype Lenses in buy Buy zone
MRNA Moderna, Inc. Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MRTN MARTEN TRANSPORT LTD Industrials Avoid ●●○ Medium Conflicting Signals 0/4 Overvalued
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MRVL Marvell Technology, Inc. Technology Avoid ●○○ Low Earnings Suspect 0/4 Overvalued
MSEX MIDDLESEX WATER CO Utilities Avoid ●●○ Medium Distressed/Deficit 0/4 Overvalued
MSFT MICROSOFT CORP Technology Avoid ●●● High Franchise 0/4 Overvalued
MSGM Motorsport Games Inc. Communication Services Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MSLE Satellos Bioscience Inc. Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MTCH Match Group, Inc. Communication Services Avoid ●●○ Medium Distressed/Deficit 0/4 Overvalued
MTEK Maris Tech Ltd. Technology Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MTLS MATERIALISE NV Technology Avoid ●○○ Low No-Moat 0/4 Overvalued
MTRX MATRIX SERVICE CO Industrials Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MTSI MACOM Technology Solutions Holdings, Inc. Technology Avoid ●●○ Medium Distressed/Deficit 0/4 Overvalued
MU MICRON TECHNOLOGY INC Technology Avoid ●●○ Medium Franchise 0/4 Overvalued
MWH SOLV Energy, Inc. Utilities Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MWYN Marwynn Holdings, Inc. Consumer Cyclical Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MXL MAXLINEAR, INC Technology Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MYGN MYRIAD GENETICS INC Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MYRG MYR GROUP INC. Industrials Avoid ●●● High Franchise 0/4 Overvalued
MYSE Myseum.AI, Inc. Technology Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
MZTI MARZETTI CO Consumer Defensive Avoid ●○○ Low Franchise 0/4 Overvalued
NAGE Niagen Bioscience, Inc. Consumer Defensive Avoid ●○○ Low Earnings Suspect 0/4 Overvalued
NAMI Jinxin Technology Holding Co Communication Services Avoid ●●○ Medium Distressed/Deficit 0/4 Overvalued
NAMS NewAmsterdam Pharma Co N.V. Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NAVN Navan, Inc. Technology Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NB NIOCORP DEVELOPMENTS LTD Basic Materials Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NBIS Nebius Group N.V. Communication Services Avoid ●○○ Low No-Moat 0/4 Overvalued
NBIX NEUROCRINE BIOSCIENCES INC Healthcare Avoid ●●● High Franchise 0/4 Overvalued
NBP NovaBridge Biosciences Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NCEW New Century Logistics (BVI) Ltd Industrials Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NCI Neo-Concept International Group Holdings Ltd Consumer Cyclical Avoid ●○○ Low No-Moat 0/4 Overvalued
NCMI National CineMedia, Inc. Communication Services Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NCNA NuCana plc Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NDRA ENDRA Life Sciences Inc. Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NDSN NORDSON CORP Industrials Avoid ●●● High Asset-Light Compounder 0/4 Overvalued
NEGG Newegg Commerce, Inc. Consumer Cyclical Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NEO NEOGENOMICS INC Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NEOV NeoVolta Inc. Industrials Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NEPH NEPHROS INC Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NESR National Energy Services Reunited Corp. Energy Avoid ●○○ Low No-Moat 0/4 Overvalued
NEUP Neuphoria Therapeutics Inc. Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NEXM NexMetals Mining Corp. Basic Materials Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NEXN Nexxen International Ltd. Communication Services Avoid ●○○ Low No-Moat 0/4 Overvalued
NFE New Fortress Energy Inc. Energy Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NFLX NETFLIX INC Communication Services Avoid ●●○ Medium Asset-Light Compounder 0/4 Overvalued
NGEN NERVGEN PHARMA CORP. Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NGNE Neurogene Inc. Healthcare Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NHIC NewHold Investment Corp. III Avoid ●○○ Low No-Moat 0/4 Overvalued
NHP National Healthcare Properties, Inc. Real Estate Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued
NIU Niu Technologies Consumer Cyclical Avoid ●○○ Low Distressed/Deficit 0/4 Overvalued